Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2023 April;114(2) > Minerva Medica 2023 April;114(2):169-77

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Medica 2023 April;114(2):169-77

DOI: 10.23736/S0026-4806.22.07847-8

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Post-traumatic stress disorder, depression and anxiety symptoms in COVID-19 outpatients with different levels of respiratory and ventilatory support in the acute phase undergoing three months follow-up

Marta FERRARIS 1, Marina MAFFONI 2 , Vincenzo DE MARZO 3, Antonia PIEROBON 2, Marinella SOMMARUGA 4, Cristina BARBARA 1, Annalisa PORCILE 1, Carmelo RUSSO 1, Lucio GHIO 5, Piero CLAVARIO 1, Italo PORTO 3

1 Cardiac Rehabilitation Center of Genoa, Azienda Sanitaria Locale ASL 3 Genovese, Genoa, Italy; 2 Unit of Psychology, Istituti Clinici Scientifici Maugeri IRCCS, Montescano Institute, Montescano, Pavia, Italy; 3 Unit of Cardiology, DICATOV-Cardiothoracic and Vascular Department, IRCCS San Martino Hospital, Genoa, Italy; 4 Unit of Psychology, Istituti Clinici Scientifici Maugeri IRCCS, Camaldoli Institute, Milan, Italy; 5 Mental Health Department, ASL 3 Genovese, Genoa, Italy



BACKGROUND: The well-known COVID-19 pandemic totally transformed people’s lives, paving the way to various psychopathological symptoms. In particular, patients may experience a short- and long-term decreasing in their wellbeing. In this vein, the aim of this paper was to assess the COVID-19 patients’ psychopathological profile (post-traumatic stress disorder, distress, anxiety and depression symptoms), detecting possible differences linked to the ventilatory treatments.
METHODS: Outpatients who recovered from COVID-19 were asked to provide socio-demographic and clinical information, and to complete a brief psychological screening evaluation (Impact of Event Scale-Revised [IES-R], Depression Anxiety Stress Scale [DASS-21]).
RESULTS: Overall, after informed consent, 163 Italian patients took part in this research. Of them, 31.9% did not undergo any ventilatory therapy, 27.6% undertook oxygen therapy, 28.2% underwent noninvasive mechanical ventilation, and 12.3% received invasive mechanical ventilation. Although no statistically significant differences were revealed among patients stratified by spontaneous breathing or ventilatory therapies, they reported statistically significant more depression (4.5+5.2 vs. 3.5+3.2; P=0.017) and anxiety (4.3+4.5 vs. 2.4+2.6; P<0.00001) symptoms than normative groups. Moreover, patients experiencing COVID-19 disease as a trauma, complained statistically significant higher levels of depression, anxiety and stress symptoms than who did not describe a clinically relevant traumatic experience (P<0.001).
CONCLUSIONS: Thus, this study suggests to healthcare professionals to consider COVID-19 experience as a potential real trauma for patients, and underlines the necessity to define patients’ psychopathological profile in order to propose tailored and effective preventive and supportive psychological interventions.


KEY WORDS: Stress disorders, post-traumatic; Respiratory distress syndrome; Anxiety; Depression; COVID-19

top of page